How Viking Therapeutics Stock Could 30x
Viking Therapeutics (NASDAQ: VKTX) has been one of the few bright spots in the healthcare sector this year. The biotech's shares have stormed higher by almost 300% year to date on the back of its midstage weight-loss candidate, VK2735.
The lowdown is that VK2735 could be a top three weight-loss medication in terms of sales, according to some analyst estimates. That's a potentially incredible opportunity for risk-tolerant investors.
Image Source: Getty Images.
Source Fool.com
Viking Therapeutics Inc Stock
€57.40
0.320%
Our community is currently high on Viking Therapeutics Inc with 5 Buy predictions and 0 Sell predictions.
With a target price of 100 € there is a hugely positive potential of 74.22% for Viking Therapeutics Inc compared to the current price of 57.4 €.
